| Literature DB >> 34632492 |
Di Yu1, Zhangke Guo2, Xin You3, Wei Peng1, Jirong Qi1, Jian Sun1, Kaihong Wu1, Xiaofeng Li2, Xuming Mo1.
Abstract
OBJECTIVES: Vascular rings are rare anomalies of congenital heart disease that cause respiratory and gastrointestinal symptoms. This study assessed the long-term outcomes of patients with vascular ring division.Entities:
Keywords: Kommerell diverticulum; Surgery; Tracheal ring; Tracheomalacia; Vascular ring
Mesh:
Year: 2022 PMID: 34632492 PMCID: PMC8858591 DOI: 10.1093/ejcts/ezab432
Source DB: PubMed Journal: Eur J Cardiothorac Surg ISSN: 1010-7940 Impact factor: 4.191
Classification of vascular ring
| Vascular ring type | No. patients ( |
|---|---|
| Complete vascular ring, | 229 (61.7) |
| Double aortic arch | 91 |
| Right arch dominant | 65 |
| Left arch dominant | 10 |
| Codominant | 16 |
| Right aortic arch with left ligamentum arteriosum | 136 |
| Aberrant left subclavian artery | 95 |
| Mirror-image branching | 41 |
| Left aortic arch, right-sided descending aorta with right ductus arteriosus | 2 |
| Incomplete vascular ring, | 142 (38.3) |
| Pulmonary artery sling | 85 |
| Left aortic arch with aberrant right subclavian artery | 56 |
| Innominate artery compressionsyndrome | 1 |
Patient symptoms at clinical presentation
| Symptoms | Preoperative no. patients | Postoperative no. patients |
|---|---|---|
| ( | ( | |
| Respiratory, | ||
| Stridor | 265 (71.4%) | 15 (4.2%) |
| Wheezing | 182 (49.1%) | 1 (0.3%) |
| Coughing | 117 (31.5%) | 2 (0.6%) |
| Shortness of breath | 56 (15.1%) | 0 (%) |
| Recurrent respiratory tract infections | 49 (13.2%) | 1 (0.3%) |
| Apnoea | 21 (5.7%) | 0 (0%) |
| Gastrointestinal, | ||
| Choking | 46 (12.4%) | 1 (0.3%) |
| Dysphagia | 12 (3.2%) | 0 (0%) |
| Emesis | 7 (1.9%) | 0 (0%) |
More than 1 symptom may occur for each patient.
Patients with residual symptoms on long-term follow-up.
Figure 1:The CONSORT diagram. ARSCA: aberrant right subclavian artery; DAA: double aortic arch; IACS: innominate artery compression syndrome; LAA: left aortic arch; LLA: left ligamentum arteriosum; PAS: pulmonary artery sling; RAA: right aortic arch; RLA: right ligamentum arteriosum.
Univariate analysis results identifying risk factors for mortality, reoperation and residual symptoms
| Variable | Mortality |
| Reoperation |
| Residual symptoms |
|
|---|---|---|---|---|---|---|
| ( | ( | ( | ||||
| Neonate | 0.59 | 0.37 | 0.008 | |||
| Yes | 1/18 | 0/18 | 2/18 | |||
| No | 11/353 | 15/353 | 18/342 | |||
| Male | 0.76 | 0.38 | 0.83 | |||
| Yes | 8/232 | 11/232 | 14/225 | |||
| No | 4/139 | 4/139 | 6/135 | |||
| Complete vascular ring | 0.005 | 0.45 | <0.001 | |||
| Yes | 1/229 | 8/229 | 10/228 | |||
| No | 11/142 | 7/142 | 10/132 | |||
| Tracheomalacia | 0.39 | <0.001 | 0.014 | |||
| Yes | 1/68 | 9/68 | 9/67 | |||
| No | 11/303 | 6/303 | 11/293 | |||
| Complete tracheal ring | <0.001 | 1.00 | 0.055 | |||
| Yes | 7/52 | 2/52 | 4/45 | |||
| No | 5/319 | 13/319 | 16/315 | |||
| Concomitant cardiac defect | 0.011 | 0.79 | 0.004 | |||
| Yes | 11/163 | 7/163 | 11/153 | |||
| No | 1/208 | 8/208 | 9/207 |
Multivariable analysis of risk factors for mortality, reoperation and residual symptoms
| Risk factor | HR (95% CI) |
| |
|---|---|---|---|
| Mortality | Complete tracheal ring | 3.51 (1.03–12.02) | 0.045 |
| Complete vascular ring | 0.24 (0.02–2.78) | 0.26 | |
| Concomitant cardiac defect | 4.51 (0.46–44.76) | 0.20 | |
| Reoperation | Tracheomalacia | 6.85 (2.44–19.25) | <0.001 |
| Residual symptoms | Tracheomalacia | 3.18 (1.29–7.88) | 0.012 |
| Neonate | 3.19 (0.60–17.15) | 0.18 | |
| Complete vascular ring | 0.34 (0.09–1.36) | 0.13 | |
| Complete tracheal ring | 1.63 (0.39–6.81) | 0.50 | |
| Concomitant cardiac defect | 2.01 (0.66–6.15) | 0.22 |
CI: confidence interval; HR: hazard ratio.
Figure 2:Rate of overall survival and freedom from reoperation related to vascular ring repair. Y-axis is truncated at 0.9.
Reinterventions by type of vascular ring
| Type of vascular ring | Time to reintervention | Type of reintervention |
|---|---|---|
| Double aortic arch | 10 days | Diaphragm plication |
| Pulmonary artery sling | 15 days | Diaphragm plication |
| Pulmonary artery sling | 3 days | Diaphragm plication |
| Double aortic arch | 5 days | Diaphragm plication |
| Double aortic arch | 7 days | Thoracic duct ligation |
| RAA, mirror-image branching, LLA | 15 days | Thoracic duct ligation |
| Pulmonary artery sling | 1 day | Endotracheal stent implantation |
| Pulmonary artery sling | 1 month | Endotracheal stent implantation |
| RAA-mirror-image branching, LLA | 2 months | Endotracheal stent implantation |
| Pulmonary artery sling | 7 days | Endotracheal stent implantation |
| RAA-mirror-image branching, LLA | 3 months | Endotracheal stent implantation |
| Double aortic arch | 1 month | Endotracheal stent implantation |
| RAA-ALSCA, LLA | 2 months | Endotracheal stent implantation |
| Pulmonary artery sling | 14 days | Interventional therapy under fibrobronchoscopy |
| Pulmonary artery sling | 1 month | Interventional therapy under fibrobronchoscopy |
ALSCA: aberrant left subclavian artery; RAA: right aortic arch; LLA: left ligamentum arteriosum.
Figure 3:Patients with severe tracheomalacia treated with 3D-printed bioresorbable airway splints: (A) preoperatively and (B) 1 year postoperatively.